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Prurigo nodularis (PN) is a pruritic condition with altered epidermal neuroanatomy as 
demonstrated previously. Here we elucidated neuroimmunological mechanisms by combining 
functional, morphological, and gene expression experiments in twelve subjects with PN and 
eight healthy controls. Subjects with PN showed a reduced intraepidermal nerve fiber density 
(IENFD) in lesional skin. Quantitative sensory testing indicated maintenance of somatosensory 
function compared to controls. None of the tested molecular markers including the neuron-
distracting SEMA3A and neuron-attracting NGF were altered in lesional vs. non-lesional skin in 
PN subjects. Accordingly, we speculate that scratching may contribute to reduced IENFD rather 
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Background 
Chronic pruritus (CP) may arise from many different diseases, and its peripheral and central 
neuroimmunological mechanisms still remain unclear1. Previous data suggest an important role 
of both histamine-dependent mechano-insensitive and histamine-independent mechano- and 
heat-sensitive epidermal C-fibers in the pathophysiology of CP2-42-4. However, molecular 
markers for CP are still ambiguous and only scarce data exist on the role of the anatomy and 
function of the peripheral nervous system for the development and maintenance of pruritus. In 
subjects with prurigo nodularis (PN), a condition characterized by the development of 
hyperkeratotic itching nodules as a result of CP and prolonged scratching, we previously 
demonstrated a reduced intraepidermal nerve fiber density (IENFD) in lesions, which 
reconstitutes after healing5. A reduced IENFD may hint towards a small-fiber neuropathy (SFN), 
which can be induced by diseases such as diabetes and results in pathologic functionality of 
cutaneous peripheral nerves6.  
 
Questions addressed 
We speculate that the reduced IENFD in PN is not related to a SFN causing pain in neuropathic 
diseases. Rather, external injury such as long standing scratching as observed in subjects with 
PN may contribute to nerve destruction without showing functional signs of a SFN (e.g. small-
fiber function related abnormalities). As inflammation may contribute to peripheral neuronal 
sensitization7, we aimed to characterize potential molecular markers for PN in lesional and non-




Twelve subjects with PN (m:f=5:7; age=50±14 years) and eight healthy controls (m:f=4:4; 
age=49±10 years) were included. Inclusion/exclusion criteria are detailed in supplementary 
table 1. There was no difference in age between groups (p=0.91). Asked for their scratching 
behavior, subjects with PN confirmed scratching of itchy nodules. 
 
Histology and IENFD  
Histology and the distribution of inflammatory cells were assessed by H&E staining of lesional 
(only subjects with PN, lower leg) biopsies. The IENFD was determined in biopsies from lesional 
skin by immunostaining with antibodies against protein gene product 9.5 (PGP 9.5; rabbit 
polyclonal, 1:200, Zytomed, Berlin, Germany) as previously described8. Since a normal IENFD 
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Expression analysis 
Gene expression was analyzed using biopsies from lesional and non-lesional skin from the 
lower leg in eight subjects with PN. Total RNA was isolated using the innuPrep RNA Mini-Kit 
(Analytik Jena, Jena, Germany) and reverse transcription was performed with oligo-dT primers 
and the RevertAid® First Strand cDNA Synthesis Kit (both by Thermo Scientific, Kalamazoo, 
USA) according to the instructions of the manufacturers. Gene expression was analyzed by 
means of quantitative real-time PCR using the ABI 7300-Real Time-PCR System (Applied 
Biosystems, Darmstadt, Germany). Gene expression of known or presumed molecular markers 
for PN and/or inflammation like interleukin (IL)-6, IL-8, tyrosine kinase A (TRKA), nerve growth 
factor (NGF), semaphorin-3A (SEMA3A), and IL-31 were analyzed in lesional and non-lesional 
skin of subjects with PN (supplementary section, supplementary table 2).  
 
Quantitative sensory testing (QST) 
To assess possible dysfunctions of peripheral large and small myelinated and unmyelinated 
nerve fibers, subjects with PN and controls underwent standardized QST performed at the left 
lower leg in lesional skin adjacent to the itchy nodules. The prurigo nodules were avoided in the 
examination. Briefly, the subjective response to graded stimuli of various modalities was 
assessed according to a standardized procedure9 (see supplementary section). 
 
Participants signed an informed consent and the study was approved by the local ethics 
committee (2007-135-f-S) and conducted according to the declaration of Helsinki. 
 
Statistics 
SPSS 22.0 (IBM, Armonk, NY, USA) was used for group comparisons using the non-parametric 
Mann-Whitney test or Wilcoxon test, as appropriate. Two-tailed statistical tests with a level of 
significance of p<0.05 were used. 
 
Results 
Histology and IENFD 
All lesional skin biopsies of subjects with PN showed typical signs of PN with 
pseudoepitheliomatous hyperplasia of the epidermis, fibrosis of the dermal collagen fibers, a 
weak to moderately dense perivascular and interstitial inflammatory infiltrate, and a reduced 
IENFD in lesional skin (range: 0.2-5.2 fibers/mm; median=1.3; normal values: >11 fibers/mm 
(female), >10 fibers/mm (male); data not shown).  
 
Gene expression analyses 
We found no differential gene expression of SEMA3A and IL-31 (p=0.07 and p=0.09) in lesional 
compared to non-lesional skin of subjects with PN (figure 1, supplementary figure 1). 
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We did not find differences in QST parameters between subjects with PN and healthy controls 
(p>0.05, supplementary table 3). Although significance was not reached, our data suggests that 
mechanical pain sensitivity (MPS) may be reduced in subjects with PN compared to controls 
(p=0.08, figure 2) suggesting an Aδ-fiber malfunction.   
 
Conclusions 
In these subjects with PN, IENFD in lesional skin was reduced, while QST profiles 
representative for C-fiber function were normal in lesional skin. In QST, a malfunction of 
cutaneous sensory C and Aδ-fibers would be reflected by pathological non-noxious and noxious 
temperature thresholds, which we did not observe here. We demonstrated previously in PN, that 
healed lesions without itch and scratching showed a full reconstitution of IENFD. Accordingly, 
we can speculate that the disturbed epidermal neuroanatomy most likely does not result from a 
functional neuropathy but rather from a mechanical damage such as scratching. Future studies 
should correlate scratching activity with the IENFD. In agreement with this hypothesis, SEMA3A 
as nerve distracting factor and NGF as nerve attracting factor10 were not up or down-regulated. 
These factors have been reported to be regulated in inflammatory diseases such as atopic 
dermatitis and alter the neuroanatomical structure5. Future studies should analyze the 
expression at protein level. Impaired descending inhibition is an alternative explanation for the 
absence of QST abnormalities is spite of neuroanatomical changes and should be addressed in 
future studies.   
In the experimental testing, we found indications for decreased MPS to pinprick stimulation, 
which may represent a reduced function of Aδ-fibers. However, MPS was not reduced and other 
parameters mediated by Aδ-fiber function were unchanged as well (e.g. cold detection and pain 
thresholds). Thus, the role of Aδ-fibers for pruritus needs further investigations.  
A limitation of this pilot study is that it might have been underpowered to show possible 
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Figure 1. Gene expression: IL-31 and SEMA3A. Relative gene expression was measured by 
means of quantitative real time PCR. Our data suggests that the expression of IL-31 (p=0.09) 
and SEMA3A (p=0.07) may be higher in lesional compared to non-lesional skin in subjects with 
prurigo nodularis (PN), however significance was not reached. Statistics was done with SPSS 
22.0. P-values were calculated using Related-Samples Wilcoxon Signed Rank Test. Dots 
indicate outlier data points lying between 1.5 and 3x of the individual interquartile range. 
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Figure 2. Quantitative sensory testing: mechanical pain sensitivity. Boxplots showing 
distribution of mechanical pain sensitivity to pinprick stimulation (8-512 mN) in subjects with PN 
and matched healthy controls. Although significance was not reached, our data suggests that 
mechanical pain sensitivity (MPS) may be reduced in subjects with PN compared to controls 
(p=0.08), NRS: numerical rating scale (0-100). PN: prurigo nodularis. The p-value was 
calculated using the Mann-Whitney U test. 
 
  
  Letter to the Editor (Experimental Dermatology) 
 Page 9 from 12 
 
 
Supplementary methods    
Inclusion and exclusion criteria 
Inclusion and exclusion criteria are presented in supplementary table 1. 
 
Supplementary table 1. Inclusion and exclusion criteria. 
Inclusion Criteria Exclusion Criteria 
• 18≤age≤70 • Neurological, psychosomatic or severe 
psychiatric disorders 
• Generalized prurigo nodularis (subjects with 
PN) 
• Diabetes mellitus 
 • Previous myocardial infarction  
 • Localized itch syndromes 
 • Pain syndrome 
 • Polyneuropathy 
 • Diseases that prevented study participation 
 • Pregnant and lactating women 
 
 
Gene expression analysis 
Gene expression was analyzed by quantitative real time PCR using the Kappa SYBR Fast Universal Kit 
(Peqlab, Erlangen, Germany). PCR reactions were carried out in duplicates using the gene specific 
primer pairs listed below. Amplification and detection was done using an ABI 7300-Real Time-PCR 
System (Applied Biosystems, Darmstadt, Germany). Threshold cycles were analyzed with the 7500 Fast 
System Software and relative gene expression was calculated by the 2^-delta delta CT method with beta 
actin as housekeeping gene. 
 
Supplementary table 2. Genes analyzed for expression by means of qPCR 
Gene ID encoded gene / protein primer sequence 
ACTB actin beta AAGGAGAAGCTGTGCTACGTC 
 
  AACCGCTCATTGCCAATGGTG 
CASP1 caspase 1 CAAACTTTTTCAGAGGGGATCG 
    GCATACTGTTTCAGCATGGCAC 
CXCL2 C-X-C motif chemokine ligand 2 CGCCCCTGGCCACTGAACTGC 
 
  CTTAACCATGGGCGATGCGG 
GAP43 growth associated protein 43 CCATGCTGTGCTGTATGAGAA 
    TGTTATGTGTCCACGGAAGC 
NFKBIA NFKB inhibitor alpha GTCAAGGAGCTGCAGGAGAT 
 
  CCATGGTCAGTGCCTTTTCT 
NFKB1 nuclear factor kappa B subunit 1 ATGTATGTGAAGGCCCATCC 
    ATAACCTTTGCTGGTCCCAC 
NGF nerve growth factor ACACTGAGGTGCATAGCGTAA 
 
  CAGTAATGTTGCGGGTCTGC 
NGFR nerve growth factor receptor CTGTTGCTGCTTCTGGGG 
    GCTCACACACGGTCTGGTTGGC 
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IL1A interleukin 1 alpha TGTGACTGCCCAAGATGAAG 
 
  AAGTTTGGATGGGCAACTGA 
IL1B interleukin 1 beta AAATACCTGTGGCCTTGGGC 
    TTTGGGATCTACACTCTCCAGCT 
IL6 interleukin 6 ACAGCCACTCACCTCTTCAG 
 
  AGTGATGATTTTCACCAGGCA 
IL8 interleukin 8 GCCTTCCTGATTTCTGCAGC 
    CAGTTTTCCTTGGGGTCCAGAC 
IL31 interleukin 31 CATCCGGGCATATCTCAAGAC 
 
  GATGAAGCGTTTACATTCATGGG 
RASA1 RAS p21 protein activator 1 GGACACCCTCTGACCCTCG 
    GCTTGCTAAACTTCCTCGCTC 
RELA RELA proto-oncogene, NF-kB subunit CACCGACAAGTGGCCATTGTG 
 
  TTCTCCTCAATCCGGTGACG 
RELB RELB proto-oncogene, NF-kB subunit ATCCTTGGGGAGAGCAGC 
    GAGGCCAGTCCTTCCACAC 
SEMA3A semaphorin 3A AATGGGAAGAACAATGTGCC 
 
  ACAGCCTACTCCGTTCCTCA 
TAC1 tachykinin precursor 1 / substance P TTAATGGGCAAACGGGATGC 
    TGCCCATTGACACAAATGAAGC 
TACR1 tachykinin receptor 1 AATGACAGGTTCCGTCTGGG 
 
  GAGCAGTTGGAGGTCAGGTC 
TNF tumor necrosis factor CTCCAGGCGGTGCTTGTT 
 
  CATGGGCTACAGGCTTGTCA 
 
  
Quantitative sensory testing (QST) 
To assess a possible dysfunction of sensory fibers and signs of central sensitization we performed a test 
battery of somatosensory testing by QST in fixed order according to the protocol developed by the 
German Research Network for Neuropathic Pain9. A non-lesioned area on the left lower leg was chosen 
for the assessments.  
Thermal thresholds were determined using a 3x3 cm contact thermode of Peltier elements (TSA II 
NeuroSensory Analyzer, Medoc Ltd., Israel) from a baseline temperature of 32°C with a ramp rate of 
1.0°C/s (cut-off: 0ºC and 50ºC). To assess detection (CDT: cold detection threshold; WDT: warmth 
detection threshold) and pain thresholds (CPT: cold pain threshold; HPT: heat pain threshold), 
participants were instructed to press a button as soon as the sensation induced by the contact thermode 
changed from a neutral temperature to a cold or warmth sensation or to a painful sensation, respectively. 
The thermal sensory limen (TSL), i.e. the difference limen for alternating warm and cold stimuli, was 
assessed by asking the subjects to press a button as soon as the sensation induced by the thermode 
changed from a neutral temperature to a cold or warmth sensation. Additionally, the number of 
paradoxical heat sensations (PHS), i.e. reports of hot or burning sensations to innocuous cold stimuli was 
recorded. To assess mechanical detection (MDT) and mechanical pain thresholds (MPT), subjects were 
asked to report when they perceived the stimulation by a set of von Frey filaments (Optihair2-Set, 
Marstock Nervtest, Germany [forces between 0.25 and 512 mN; diameter: 0.5 mm]) or whether 
stimulation with a series of weighted pins PinPrick, MRC Systems, Heidelberg, Germany [forces between 
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8 and 512 mN; diameter: 0.25 mm]) were painful. Mechanical pain sensitivity (MPS) was assessed as the 
stimulus-response function for pinprick stimulation using the pinprick set described above, while dynamic 
mechanical allodynia (DMA) was measured as the pain to stimulation with a cotton wisp (3 mN), a cotton 
wool tip (100 mN) and a brush (200–400 mN). The difference in pain intensity evoked by a single pinprick 
stimulation (256 mN) and by the application of a series of 10 pinprick stimuli (256 mN, 1 Hz) determined 
the wind-up ratio. Finally vibration detection thresholds (VDT) were assessed using a tuning fork 
(AESCULAP, B. Braun Company, Germany; 64 Hz, 8/8 scale) and pressure pain thresholds (PPT) with a 




Supplementary table 3. Comparison of quantitative sensory testing parameters in subjects with 
PN and healthy controls. There was a trend in decreased MPS in subjects with PN compared to 
controls (p=0.08). No significances or trends were observed for the remaining parameters (p>0.1). Data 
are shown as median [interquartile range]. PN: prurigo nodularis, HC: healthy controls. CDT: cold 
detection threshold; CPT: cold pain threshold; DMA: dynamic mechanic allodynia; HPT: heat pain 
threshold; MDT: mechanical detection threshold; MPS: mechanical pain sensitivity; MPT: mechanical pain 
threshold; PHS: paradoxical heat sensation; PPT: pressure pain threshold; TSL: thermal sensory limen; 
VDT: vibration detection threshold; WDT: warmth detection threshold; WUR: wind-up ratio. 
 
QST parameter PN HC p-value 
CDT (ºC) 4.0 [2.1;5.7]  3.2 [2.3;-4.3] 0.68 
WDT (ºC) 7.8 [4.2;12.0] 5.9 [4.0;9.1] 0.68 
TSL (ºC) 9.7 [7.5;12.3] 7.8 [7.0;11.0]   0.38 
PHS (/3) 0.5 [0;1] 0 [0;0]  0.16 
CPT (ºC) 0.8 [0;3.5]  0 [0;0] 0.18 
HPT (ºC) 48.7 [47.4;49.5] 46.7 [45.6;48.9]  0.38 
MDT (mN) 15.5 [6.3;20.1] 5.1 [2.6;10.8] 0.12 
MPT (mN) 9.5 [6.6;13.7] 8.1 [5.7;10.2] 0.38 
MPS (NRS) 4.3 [0.5;7.4] 16.8 [7.1;23.2] 0.08 
DMA (NRS) 0 [0;0] 0 [0;5] 0.43 
WUR 1.8 [1.6;2.8] 1.6 [1.3;1.9] 0.30 
VDT (/8) 6.3 [5.9;6.8] 6.2 [5.6;8] 0.91 
PPT (kPa) 271 [203;328] 319 [301;425] 0.12 
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Supplementary figures 
   
 
Supplementary figure 1. Relative gene expression was measured by means of quantitative real time 
PCR in subjects with prurigo nodularis (PN) (n=8). Only two genes showed a trend towards higher 
expression in lesional compared to non lesional skin, IL31 (p=0.09) and SEMA3A (p=0.07), respectively. 
Statistic was done with SPSS 22. P-values were calculated using Related-Samples Wilcoxon Signed 
Rank Test. 
 
 
 
